PETALING JAYA: IHH Healthcare Bhd co-led a minority investment in Singapore-based telehealth company Doctor Anywhere (DA), as part of DA’s US$27 million (RM116 million) Series B round to expand its platform and enter new geographies in Southeast Asia.
The investment is in line with IHH’s strategy to partner with innovative companies that deploy cutting-edge healthcare technology. The aim is to enhance the patient’s experience, treatment and clinical outcomes across its network of 77 hospitals in 10 countries.
IHH Healthcare managing director and CEO Dr Kelvin Loh said the partnership with DA will enable IHH to expand its digital ecosystem and better support clients with IHH’s full suite of healthcare services.
“DA’s end-to-end digital platform enables patients to schedule and receive virtual consultations with a doctor anytime, anywhere. Prescribed medications can also be delivered right to their home. The partnership is immediately synergistic in Singapore which is one of IHH’s home markets,” he said in a statement today.
DA currently serves more than one million users.
Beyond Singapore, its mobile app is also available in Thailand as well as in key Vietnamese cities of Hanoi and Ho Chi Minh City.
In addition to tele-consultations and drug delivery, DA users can also purchase health and wellness products on its online marketplace.
DA founder and CEO Lim Wai Mun said IHH’s strong global healthcare services network and deep pool of expertise, would complement DA’s services to make quality healthcare more accessible to patients in the region.
